Back to Results
First PageMeta Content
Mir-200 / Mir-205 / Mir-31 / Ovarian cancer / Let-7 microRNA precursor / Mir-223 / Mir-22 / Non-coding RNA / Mir-145 / MicroRNA / Genetics / Biology


Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
Add to Reading List

Open Document

File Size: 514,68 KB

Share Result on Facebook

City

Article / /

Company

S.-M. Park A. E. / New England Journal / Creative Commons / R. J. Flavin S. A. / Hindawi Publishing Corporation / /

Country

Japan / United States / /

Currency

pence / /

/

Event

Product Issues / /

Facility

Keio University / Japan Public Health Center / /

IndustryTerm

active site / miRNAs show site / therapy of cancer / Treatment of Ovarian Cancer / cancer therapy / Cancer Therapeutics / defective chromosomal site / therapy for ovarian cancer / miRNA processing / /

MedicalCondition

recurrent ovarian cancer / ovarian cancers / undifferentiated cancer / serous adenocarcinoma / Ovarian cancer / established tumors / platinum-resistant endometrial cancer / metastasis / human epithelial ovarian cancer / serous cystadenoma / advanced ovarian cancer / silenced tumor / solid cancer / paclitaxel-resistant ovarian cancer / human cancers / hereditary ovarian cancer / Carcinoma / testicular germ cell tumors / ovarian tumors / Mucinous adenocarcinoma / difficult and recurrent ovarian cancer / epithelial ovarian cancer / breast cancer / human ovarian cancer / PTEN tumor / high-grade serous carcinomas / infertility / relapsed orrefractory acute myeloid leukemia / 2102Ep embryonal carcinoma / cancers / tumor / serous ovarian carcinoma / Malignant tumors / advanced ovarian carcinoma / ovarian clear cell carcinoma / cancer / disease / common female cancer / induced metastasis / Gynecological Cancer / undifferentiated carcinoma / human ovarian epithelial neoplasms / carcinogenesis / invasive epithelial ovarian cancer / Molecular Cancer / Endocrine-Related Cancer / suboptimal residual tumor / epithelial ovarian carcinoma / Leukemia Lymphoma / acute lymphoblastic leukemia / clear cell adenocarcinoma / Lung cancer / clear cell ovarian cancer / peritoneal metastasis / platinum-resistant / epithelial ovarian cancer / Introduction Ovarian cancer / serous ovarian carcinomas / diseases / clear cell carcinoma / borderline tumor / hematologic malignancy / Endometrioid adenocarcinoma / /

MedicalTreatment

Chemotherapy / surgery / radiation / cancer therapy / minimally invasive procedures / Gene therapy / /

Organization

National Academy of Sciences / Japan Medical Association / Medical Research Encouragement Fund / Japan Society for the Promotion of Science / School of Medicine / Keio University / Japan Public Health Center / Keio University Medical Science Fund / Daisuke Aoki Department of Obstetrics and Gynecology / /

Person

C. J. Creighton / Miho Iida / Kenta Masuda / Kiyoko Umene / Megumi Yanokura / Hiroyuki Nomura / Mase / Yuya Nogami / Yong-Sang Song / Fumio Kataoka / Daisuke Aoki / /

Position

Academic Editor / gonadotropin and activin receptor messenger / /

Product

carboplatin / cisplatin / LG 200C Cellular Phone / paclitaxel / chromosomal site / /

PublishedMedium

Cancer Research / The American Journal / Proceedings of the National Academy of Sciences / PLoS ONE / The New England Journal of Medicine / Nucleic Acids Research / /

Technology

radiation / stem cells / apoptosis / Gene therapy / drug discovery / DNA Chip / gene expression / Chemotherapy / treating cancer / /

URL

http /

SocialTag